Statistics

Total Visits

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group52

Select a period of time:

Number of views in the range

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group28

Views

Views
February 20255
March 20255
April 20253
May 20251
June 20254
July 202510
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Singapore5
Brazil5
Germany3
Argentina1
Bolivia1
Canada1
Spain1
Paraguay1
 

Top cities views

Views
Nuremberg3
São Paulo2
Brampton1
Ciudad del Este1
Council Bluffs1
Goiânia1
Guapimirim1
La Paz1
Laferrere1
São Luís1